Vitamin D in patients with androgenetic alopecia

Introduction: Androgenetic alopecia (AGA), commonly referred to as pattern hair loss, is a prevalent condition affecting both men and women, characterized by progressive hair thinning and loss in a patterned distribution. The pathophysiology of AGA is complex, involving genetic predisposition, hormonal influences, particularly dihydrotestosterone (DHT), and other factors such as inflammation and possibly micronutrient status, including vitamin D levels. This article delves into the current understanding of the role of vitamin D in patients with AGA, examining the evidence linking vitamin D to hair growth and loss, the mechanisms through which vitamin D may influence hair follicle biology, and the potential therapeutic implications of these findings.

The Role of Vitamin D in Hair Follicle Biology: Vitamin D, a fat-soluble vitamin primarily obtained from sunlight exposure and dietary intake, is well known for its role in bone health and calcium metabolism. However, its role in skin and hair follicle biology has garnered increasing attention. Vitamin D receptors (VDRs) are expressed in various cells, including keratinocytes and dermal papilla cells in hair follicles, indicating a potential direct role in hair cycle regulation and growth.

Research has shown that VDR activation is crucial for the initiation of the anagen phase, the active growth phase of the hair cycle. Mice deficient in VDR exhibit hair loss and impaired hair regrowth, underscoring the importance of vitamin D signaling in hair follicle cycling and maintenance. These findings suggest that vitamin D might influence hair follicle cycling, promoting the anagen phase and possibly preventing premature transition to the telogen phase, the resting and shedding phase of the hair cycle.

Vitamin D Levels in Androgenetic Alopecia: Studies investigating the relationship between vitamin D levels and AGA have yielded mixed results. Some research indicates lower serum vitamin D levels in individuals with AGA compared to controls, suggesting a potential link between vitamin D deficiency and AGA. However, other studies have not found significant differences in vitamin D levels between those with AGA and those without, indicating that the relationship may be more complex and influenced by other factors such as genetics, age, and overall health status.

A meta-analysis of observational studies could provide a more comprehensive understanding of this relationship, considering potential confounding variables and the heterogeneity of study populations. Such analyses could help determine whether vitamin D deficiency is a contributing factor to AGA or merely an associated finding. There has been one recent attempt to conduct a meta-analysis for non-scarring alopecias, including male and female pattern hair loss. However, the wide variability in methods used and data analysis between different research studies made the meta-analysis very challenging. Overall, the authors concluded that individuals with non-scarring alopecias tend to have lower 25(OH)D levels as compared to healthy controls.

Mechanisms Linking Vitamin D and Androgenetic Alopecia: The potential mechanisms through which vitamin D could influence AGA are multifaceted. Vitamin D might modulate hair follicle biology in several ways:

  1. Regulation of Hair Cycle: Vitamin D could promote hair follicle entry into the anagen phase and prolong this growth phase, enhancing hair density and thickness.
  2. Anti-inflammatory Effects: Given that inflammation can contribute to hair follicle miniaturization in AGA, the anti-inflammatory properties of vitamin D might mitigate inflammatory processes around hair follicles.
  3. Modulation of Immune Function: Vitamin D’s role in immune regulation might impact autoimmune activities associated with hair follicle damage in AGA.
  4. Influence on Keratinocytes: As vitamin D affects keratinocyte proliferation and differentiation, it might influence hair shaft production and quality.

Clinical Implications and Therapeutic Potential: The clinical implications of vitamin D’s role in AGA are significant, offering potential therapeutic avenues. If vitamin D deficiency is consistently associated with AGA, supplementing with vitamin D could be a simple, cost-effective intervention for individuals with both AGA and low vitamin D levels. However, the efficacy of vitamin D supplementation in treating AGA remains to be firmly established through randomized controlled trials. In addition, the benefits of using vitamin alongside other treatments such as minoxidil or finasteride have not been investigated.

It is also important to consider the optimal vitamin D levels for hair health, as excessive vitamin D can have adverse side effects. Identifying the therapeutic range specific to hair growth promotion is crucial for safe and effective treatment, but at this time the research to confirm the appropriate level of vitamin D for hair health has not been done. An alternative to supplements may be to use a topical applied cream containing vitamin D; there are such creams available (called calcipotriol).

Current Research and Future Directions: Current research into the role of vitamin D in AGA is ongoing, with studies focusing on elucidating the molecular mechanisms of vitamin D action on hair follicles, determining the epidemiological relationship between vitamin D levels and AGA, and evaluating the therapeutic potential of vitamin D supplementation in AGA treatment. Future research will likely focus on: Conducting larger-scale, well-designed epidemiological studies to clarify the relationship between vitamin D levels and AGA. Exploring the genetic and molecular mechanisms underlying vitamin D’s effects on hair follicle biology. Determining the efficacy and safety of vitamin D supplementation in the management of AGA through randomized controlled trials. Investigating the potential synergistic effects of vitamin D with other treatments for AGA.

Conclusion

The role of vitamin D in androgenetic alopecia remains a compelling area of research with significant clinical potential. While there is evidence to suggest a link between vitamin D and hair follicle function, the exact nature of this relationship and its therapeutic implications require further investigation. Understanding the mechanisms through which vitamin D influences hair growth and establishing clear guidelines.

Bibliography

1.
Kong J, Li XJ, Gavin D, Jiang Y, Li YC. Targeted expression of human vitamin d receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol. 2002 Apr;118(4):631–8.
1.
Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP. Development and progression of alopecia in the vitamin D receptor null mouse. J Cell Physiol. 2006 May;207(2):340–53.
1.
Amor KT, Rashid RM, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010 Feb 15;16(2):3.
1.
Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101–7.
1.
Fawzi MMT, Mahmoud SB, Ahmed SF, Shaker OG. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. J Cosmet Dermatol. 2016 Dec;15(4):318–23.
1.
Sanke S, Samudrala S, Yadav A, Chander R, Goyal R. Study of serum vitamin D levels in men with premature androgenetic alopecia. Int J Dermatol. 2020 Sep;59(9):1113–6.
1.
Zhao J, Sheng Y, Dai C, Qi S, Hu R, Rui W, et al. Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population. J Cosmet Dermatol. 2020 Nov;19(11):3115–21.
1.
Kondrakhina IN, Verbenko DA, Zatevalov AM, Gatiatulina ER, Nikonorov AA, Deryabin DG, et al. A Cross-sectional Study of Plasma Trace Elements and Vitamins Content in Androgenetic Alopecia in Men. Biol Trace Elem Res. 2021 Sep;199(9):3232–41.
1.
Zubair Z, Kantamaneni K, Jalla K, Renzu M, Jena R, Jain R, et al. Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review. Cureus. 2021 Dec;13(12):e20431.
1.
Tran PT, Chen A, Yi L, Goh C. Vitamin D Levels in Alopecia Areata and Other Alopecias: A Retrospective Case- Control Study at a Single Institution. Int J Trichology. 2022;14(5):175–7.
1.
Chen Q, Tao Q, Zhu Q, Zhu J, Du X. Association Between Trichoscopic Features and Serum Hormone Levels and Vitamin D Concentration in Patients with Androgenetic Alopecia in Eastern China: A Cross-Sectional Study. Clin Cosmet Investig Dermatol. 2023;16:2547–55.
1.
Chen Y, Dong X, Wang Y, Li Y, Xiong L, Li L. Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis. J Cosmet Dermatol. 2024 Apr;23(4):1131–40.